New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas

Spanish researchers told the European Cancer Conference in Barcelona that they have found that a chemotherapy regimen of irinotecan and cisplatin produced rapid clinical responses in childhood brain stem glioma, and shrank the tumors by more than 20 percent in all six children enrolled in a clinical trial.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <em> <strong> <cite><p><br><i><b><center><ul><li><div><html5:figure><html5:figcaption>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
Sorry, we know you're not a spambot, but they're out there